<?xml version="1.0" encoding="UTF-8"?>
<p>As the number of COVID-19 cases increases worldwide, new symptoms have been reported, such as nausea, diarrhea, skin rash, and loss of taste and/or smell [
 <xref rid="ref7" ref-type="bibr">7</xref>, 
 <xref rid="ref8" ref-type="bibr">8</xref>]. In addition to the symptomatic patients, initial studies showed that a considerable amount of COVID-19 patients are asymptomatic (18–30%) or have mild symptoms [
 <xref rid="ref9" ref-type="bibr">9</xref>–
 <xref rid="ref11" ref-type="bibr">11</xref>], whereas hospitalization and mortality rates increase with patient’s age [
 <xref rid="ref12" ref-type="bibr">12</xref>]. The severity of the infection is related to the age of the patient and the presence of additional chronic diseases, such as hypertension, diabetes, and cancer [
 <xref rid="ref13" ref-type="bibr">13</xref>]. Besides challenges on detecting evidence on virulence changes of such a pathogen that is spreading very fast, there is not any solid report highlighting a mutation that affects the biological features of the virus.
</p>
